What is the recommended dosage and treatment duration for Benfotiamine (Thiamine) 100mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benfotiamine (Thiamine) 100mg Dosage and Treatment Duration

For most clinical applications, benfotiamine should be administered at a dose of 100-300mg daily for at least 6 weeks to evaluate effectiveness. 1

Recommended Dosing Regimens

  • For mild thiamine deficiency, start with 100mg daily orally for one week, followed by maintenance at 50-100mg daily 2
  • For treatment of diabetic neuropathy, higher doses of 150-300mg daily have shown better efficacy than lower doses 3
  • For optimal therapeutic effect in painful diabetic neuropathy, doses of 150-320mg daily divided into multiple doses have demonstrated significant improvement in symptoms 3
  • For maintenance therapy after proven deficiency, 50-100mg daily orally is recommended 2

Route of Administration

  • Oral benfotiamine is generally safe and well-absorbed in most patients 1
  • Intravenous administration may be more appropriate for acute deficiency or severe symptoms at doses of 100-300mg/day 2
  • For patients with alcohol-related gastritis or malabsorption issues, the IV route is preferred due to poor oral absorption 2

Duration of Treatment

  • Minimum treatment duration should be 6 weeks to properly evaluate effectiveness 1
  • For diabetic neuropathy, studies have shown significant improvements after 3-6 weeks of therapy, with greater improvements seen with longer treatment duration 3, 4
  • For patients with alcoholic liver disease, treatment may need to be extended to 2-3 months 2
  • For maintenance therapy after deficiency is corrected, ongoing supplementation at 50-100mg daily is recommended 2

Safety Considerations

  • Benfotiamine has no established upper limit for toxicity, with excess being excreted in urine 1
  • Clinical studies have shown benfotiamine to be well-tolerated at doses up to 1200mg in single-dose studies 5
  • Doses exceeding 400mg may occasionally cause mild side effects such as nausea, anorexia, and mild ataxia 1
  • Multiple ascending dose studies have shown moderate accumulation of thiamine and thiamine diphosphate with repeated administration 5

Special Clinical Scenarios

  • For patients with bariatric surgery history or prolonged vomiting/dysphagia, higher doses (200-300mg daily) may be needed 2
  • For patients with diabetic cardiomyopathy, doses of 100mg/kg/day have shown benefit in experimental models 6
  • For patients with alcohol dependence at low risk of complications, 100-250mg daily is recommended for maintenance after initial higher-dose treatment 7

Monitoring

  • Measuring RBC or whole blood thiamine diphosphate (ThDP) is recommended for patients with suspected thiamine deficiency 1, 2
  • Monitoring is particularly important in patients with neurological symptoms, cardiomyopathy, or those on prolonged medical nutrition 2
  • Clinical response should be assessed after 3 weeks of therapy, as significant improvements have been observed at this timepoint in clinical studies 3

References

Guideline

Thiamine Dosage for Treating Tremors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Thiamine Supplementation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2008

Research

[Thiamine (vitamin B1) treatment in patients with alcohol dependence].

Presse medicale (Paris, France : 1983), 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.